Cargando…
VEGF blockade enhances the antitumor effect of BRAF(V) (600E) inhibition
The development of resistance remains a major obstacle to long‐term disease control in cancer patients treated with targeted therapies. In BRAF‐mutant mouse models, we demonstrate that although targeted inhibition of either BRAF or VEGF initially suppresses the growth of BRAF‐mutant tumors, combined...
Autores principales: | Comunanza, Valentina, Corà, Davide, Orso, Francesca, Consonni, Francesca Maria, Middonti, Emanuele, Di Nicolantonio, Federica, Buzdin, Anton, Sica, Antonio, Medico, Enzo, Sangiolo, Dario, Taverna, Daniela, Bussolino, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286370/ https://www.ncbi.nlm.nih.gov/pubmed/27974353 http://dx.doi.org/10.15252/emmm.201505774 |
Ejemplares similares
-
Dual VEGFA/BRAF targeting boosts PD‐1 blockade in melanoma through GM‐CSF‐mediated infiltration of M1 macrophages
por: Comunanza, Valentina, et al.
Publicado: (2023) -
Correction to: The role of redox system in metastasis formation
por: Cencioni, Chiara, et al.
Publicado: (2021) -
The role of redox system in metastasis formation
por: Cencioni, Chiara, et al.
Publicado: (2021) -
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAF(V600E)-Mutant Colorectal Cancer
por: Napolitano, Stefania, et al.
Publicado: (2023)